In this study, we investigated the possible effect of Δ9-tetrahydrocannabinol (THC), a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, on metabolic control and vascular complications of diabetes in streptozotocin/nicotinamide (STZ/NIC) induced type 2 diabetes mellitus.
Type 2 diabetes was induced with 65 mg/kg STZ, 15 minute later 85 mg/kg NIC was given intraperitoneally (i.p.) to rats. Three days after diabetes induction, THC (3 mg/kg/day, i.p.) was given for 7 days to diabetic rats. Body weight and plasma glucose levels of rats were measured in all groups before and at the end of 3 weeks after diabetes induction. Acetylcholine (Ach) and sodium nitroprusside (SNP) potency and maximum relaxant effects were calculated on aortic rings pre-contracted with noradrenaline (NA).
At the end of 3 weeks, blood glucose levels of diabetic group significantly increased in comparison with the control group. Increased plasma glucose levels were significantly decreased by the treatment of THC. Ach induced relaxation was impaired whereas endothelium-independent relaxation to SNP was unaffected on isolated diabetic rat aorta. THC treatment enhanced Ach induced relaxation on diabetic rat aortas.
These results suggested that THC improved endothelium-dependent relaxation in STZ/NIC induced diabetic rat aorta and that these effects were mediated at least in part, by control of hyperglycemia and enhanced endothelial nitric oxide bioavailability.
Ajay M , Achike FI, Mustafa AM, Mustafa MR: Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract. 73, 1–7 (2006)
Bagi Z , Koller A, Kaley G: PPAR gamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with type 2 diabetes. Am. J. Physiol. 286, 742–748 (2004)
Bisogno T , Melck D, Bobrov , MYu, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V: N-acyl-dopamines: novel synthetics CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. 351, 817–824 (2000)
Carroll CB , Zeisler ML, Hanemann CO, Zajicek JP: Δ9-THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease Neuropathol. Appl. Neurobiol. 38, 535–547 (2012)
De Vriese AS , Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130, 963–974 (2000)
Ferré P : The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53, 43–50 (2004)
Frisher M , White S, Varbiro G, Voisey C, Perumal D, Crome I, Khideja N, Bashford J: The role of cannabis and cannabinoids in diabetes. The British Journal of Diabetes and Vascular Disease 10, 267–273 (2010)
Fortes ZB , Garcia LJ, Scivoletto R: Vascular reactivity in diabetes mellitus: Role of the endothelial cell. Br. J. Pharmacol. 79, 771–781 (1983)
Furchgott RF , Vanhoutte PM: Endothelium-derived relaxing and contracting factors. FASEB J. 3, 2007–2018 (1989)
Gallant M , Odei-Addo F, Frost CL, Levendal RA: Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes Phytomedicine 16, 942–949 (2009)
Hammes HP , Federoff HJ, Brownlee M: Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol. Med. 1, 527–534 (1995)
Hampson AJ , Grimaldi M, Axelrod J, Wink D: Cannabidiol and (−)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. 95, 8268–8273 (1998)
Ho WS , Hiley CR: Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br. J. Pharmacol. 138, 1320–1332 (2003)
Horváth B , Mukhopadhyay P, Haskó G, Pacher P: The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. Am. J. Pathol. 180, 432–442 (2012)
Hsueh WA , Bruemmer D: Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease. Hypertension 43, 297–305 (2004)
Klein TW , Lane B, Newton CA, Friedman H: The cannabinoid system and cytokine network. Proc. Soc. Exp. Biol. Med. 225, 1–8 (2000)
Liu J , Li H, Burstein SH, Zurier RB, Chen JD: Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Mol. Pharmacol. 63, 983–992 (2003)
Majithiya JB , Paramar AN, Balaraman R: Pioglitazone, a PPAR gamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats. Cardiovasc. Res. 66, 150–161 (2005)
Masiello P , Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G: Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47, 224–229 (1998)
Matias I , Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, Roche R, Maj M, Pagotto U, Monteleone P, Di Marzo V: Regulation, function and dysregulation of endocannabinoids in models of adopise and β-pancreatic cells in obesity and hyperglycaemia. J. Clin. Endocrinol. Metab. 91, 3171–3180 (2006)
Mulhern M , Docherty JR: Effect of experimental diabetes on the responsiveness of rat aorta. Br. J. Pharmacol. 97, 1007–1012 (1989)
Nogueiras R , Veyrat-Durebex C, Suchanek PM, Klein M, Tschöp J, Caldwell C, Woods SC, Wittmann G, Watanabe M, Liposits Z, Fekete C, Reizes O, Rohner-Jeanrenaud F, Tschöp MH: Peripheral, but not central, CB1 antagonism provides food intake-independent benefits in diet-induced obese rats. Diabetes 57, 2977–2991 (2008)
Offertáler L , Mo FM, Bátkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G: Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol. Pharmacol. 63, 699–705 (2003)
O’Sullivan SE , Kendall DA, Randall MD: The vascular effects of Δ9-tetrahydrocannabinol (THC) and its interactions with the endocannabinoid anandamide. Br. J. Pharmacol. 145, 514–526 (2005)
O’Sullivan SE , Tarling EJ, Bennett AJ, Kendall DA, Randall MD: Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma. Biochem. Biophys. Res. Commun. 25, 824–831 (2005)
O’Sullivan SE , Kendall DA, Randall MD: Vascular effects of D9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. Eur. J. Pharmacol. 507, 211–221 (2005)
Ozyazgan S , Kutluata N, Afşar S, Ozdaş SB, Akkan AG: Effect of glucagon-like peptide-1(7–36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats. Pharmacology 74, 119–126 (2005)
Özşelikay AT , Tay A, Dinşer T, Meral S, Yildizoğlu-Ari N, Altan VM: The effects of chronic L-arginine treatment on vascular responsiveness of streptozotocin-diabetic rats. Gen. Pharmacol. 33, 299–306 (1999)
Picard F , Auwerx J: PPAR(γ) and glucose homeostasis. Annu. Rev. Nutr. 22, 167–197 (2002)
Pieper GM , Gross GJ: Selective impairment of endothelium-dependent relaxation by oxygen-derived free radicals: distinction between receptor versus non-receptor mediator. Blood Vessels 26, 44–47 (1989)
Rangwala SM , Lazar MA: Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol. 25, 331–336 (2004)
Sakuma I , Stuehr DJ, Gross SS, Nathan C, Levi R: Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc. Natl. Acad. 85, 8664–8667 (1988)
Shinozaki K , Ayajiki K, Kashiwagi A, Masada M, Okamura T: Malfunction of vascular control in lifestyle-related diseases: mechanisms underlying endothelial dysfunction in the insulin-resistant state. J. Pharmacol. Sci. 96, 401–405 (2004)
Silan C , Uzun O, Comunoğlu NU, Gokşen S, Bedirhan S, Cengiz M: Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol: Biol. Pharm. Bull. 30, 79–83 (2007)
Stephens JM , Lee J, Pilch PF: Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptormediated signal transduction: J. Biol. Chem. 272, 971–976 (1997)
Wang SB , Yang XY, Tian S, Yang HG, DuGH: Effect of salvianolic acid A on vascular reactivity of streptozotoc-ininduced diabetic rats. Life Sci. 85, 499–504 (2009)
Wu Z , Xie Y, Morrison RF, Bucher NL, Farmer SR: PPARγ induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPα during the conversion of 3T3 fibroblasts into adipocytes. J. Clin. Invest. 101, 22–32 (1998)
Zobalı F , Şakici I, Karasu C: Effects of peroxynitrite on the reactivity of diabetic rat aorta. Pharmacology 63, 58–64 (2001)